Sarepta Announces FDA Approval of ELEVIDYS

Dr. Gordon Smith talks with Dr. Hoda Abdel-Hamid about the recent FDA approval for the first ever gene therapy for Duchenne muscular dystrophy.
Visit NPUb.org/Podcast for associated article links.

[@kentneumann5209]

They should have opened the discussion with the 3.5 million dollar cost per patient.

[@dayanemoraesvieirasouza2478]

Eu acho muito caro

[@sarabnagra3456]

Very costly 😢

[@kentneumann5209]

$3.5 million per patient.